NCT00714298View on ClinicalTrials.gov

Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room.

NACompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Acute Coronary Syndrome
Interventions
OTHER

Measure of Initial heart fatty acid binding protein and ischemia modified albumin

Initial heart fatty acid binding protein and ischemia modified albumin will be measured after patient's arrival in the emergency room. The aim of the study is to analyse the predictive value of association of heart fatty binding protein and ischemia modified albumin for non ST segment elevation acute coronary syndrome diagnosis in the first hour of management in the emergency room.Treating physicians, biologist physician will be blinded to the results of the markers.

Trial Locations (1)

31059

Emergency department Rangueil, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT00714298 - Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room. | Biotech Hunter | Biotech Hunter